Former President Bill Clinton’s foundation last year signed a deal with privately held Guava Technologies Inc. to make smaller CD4 counting machines available in Africa at a discount
PointCare Technologies Inc., which makes a hematology device used for managing anti-retroviral therapy for HIV/AIDS patients, was one of the 22 winners selected this week in the World Bank Development Marketplace.
The competitive grant program funds creative, small-scale development projects that have the potential to be expanded or replicated.
Privately held PointCare was one of 104 finalists, selected from 3,000 proposals, who showcased their proposal to judges in Washington, D.C., this week.
PointCare’s portable AuRICA NOW testing equipment, which can be operated by nonlaboratory-trained personnel in rural areas, enables HIV-infected patients to be qualified for anti-retroviral therapy, the company said.
The project, which will receive $198,300 from the World Bank, will be carried out at St. Gabriel’s Hospital in Malawi and at 11 outreach clinics and six health centers in the area.
Setup by Petra B. Krauledat and husband W. Peter Hansen after their journey through the sub-Saharan Africa, where they talked to medical workers and patients about the need for a better way to analyze blood for the crucial immune-system cells that signal when a patient needs to begin taking anti-retroviral medicines.